| ANOVA | Analysis of Variance |
| CNS | Central Nervous System |
| CSC | Cancer Stem Cells |
| Ct | Cycle threshold |
| EMT | Epithelial Mesenchymal Transition |
| EGF | Epidermal Growth Factor |
| FBS | Fetal Bovine Serum |
| FGF2 | Fibroblast Growth Factor |
| GBM | Glioblastoma Multiforme |
| GBM-BioDP | Glioblastoma Bio Discovery Portal |
| HK | Housekeeping genes |
| IDH1 | isocitrate dehydrogenase 1 |
| IDH2 | isocitrate dehydrogenase 2 |
| IL | Interleukin |
| IFN | Interferon |
| IPA | Ingenuity Pathway Analysis |
| MGMT | O-6-methylguanine-FNA methyltransferase |
| miRNA | micro-RNA |
| NCI | National Cancer Institute |
| PCA | Principal Component Analysis |
| PD-L1 | Ligand of Programmed Death Ligand 1 |
| qRT-PCR | quantitative Real Time Polymerase Chain Reaction |
| RIN | RNA Integrity Number |
| TCGA | The Cancer Genome Atlas |
| TGF | Transforming Growth Factor |
| TNF | Tumor Necrosis Factor |
| TTFields: | Tumor Treating Fields |
| TMZ | Temozolomide |
| UTR | untranslated region |